At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
HCC Warrior Met Coal LLC
Market Closed 04-24 16:00:00 EDT
86.66
-1.96
-2.21%
盘后86.66
+0.000.00%
17:31 EDT
High88.77Low85.69Vol836.69K
Open86.76D1 Closing88.62Amplitude3.48%
Mkt Cap4.56BTradable Cap4.46BTotal Shares52.57M
T/O72.70MT/O Rate1.63%Tradable Shares51.47M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Earning Preview: Warrior Met Coal LLC this quarter’s revenue is expected to increase by 67.57%, and institutional views are bullish
Earnings Agent  ·  04-23
Earning Preview: Warrior Met Coal LLC this quarter’s revenue is expected to increase by 67.57%, and institutional views are bullish
HCC Wins Rs 2,917 Crore CIDCO Water Infrastructure Contract in Joint Venture
TIPRANKS  ·  04-24 13:55
HCC Wins Rs 2,917 Crore CIDCO Water Infrastructure Contract in Joint Venture
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Enters Phase Ⅱ Trial with First Patient Dosing in Gastric Cancer, Pioneering Enhanced Immunotherapy Combination Strategies
GlobeNewswire  ·  04-21
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Enters Phase Ⅱ Trial with First Patient Dosing in Gastric Cancer, Pioneering Enhanced Immunotherapy Combination Strategies
Warrior Met Coal Keeps Quarterly Dividend at $0.08 per Share, Payable May 7 to Holders of Record May 1
MT Newswires Live  ·  04-21
Warrior Met Coal Keeps Quarterly Dividend at $0.08 per Share, Payable May 7 to Holders of Record May 1
Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026
GlobeNewswire  ·  04-21
Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026
Warrior Met Coal declares $0.08 quarterly cash dividend
Reuters  ·  04-21
Warrior Met Coal declares $0.08 quarterly cash dividend
Sirtex Medical's DOORwaY90 Study Demonstrates 100% Local Tumor Control with SIR-Spheres®, Setting a New Benchmark in Y-90 for HCC
prnewswire  ·  04-13
Sirtex Medical's DOORwaY90 Study Demonstrates 100% Local Tumor Control with SIR-Spheres®, Setting a New Benchmark in Y-90 for HCC
Warrior Met Coal (HCC) Valuation Check After Sector Weakness And Analyst Downgrade
Simply Wall St.  ·  04-13
Warrior Met Coal (HCC) Valuation Check After Sector Weakness And Analyst Downgrade
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Biliary Tract Cancer Following Positive Safety and Preliminary Efficacy Results
GlobeNewswire  ·  04-09
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Biliary Tract Cancer Following Positive Safety and Preliminary Efficacy Results
Warrior Met Coal (HCC) Receives a Hold from RBC Capital
TIPRANKS  ·  04-09
Warrior Met Coal (HCC) Receives a Hold from RBC Capital
Press Release: Warrior Sets Date for First Quarter 2026 Earnings Announcement and Investor Conference Call
Dow Jones  ·  04-08
Press Release: Warrior Sets Date for First Quarter 2026 Earnings Announcement and Investor Conference Call
Do Analyst Downgrades And Weaker Coal Outlook Change The Bull Case For Warrior Met Coal (HCC)?
Simply Wall St.  ·  04-04
Do Analyst Downgrades And Weaker Coal Outlook Change The Bull Case For Warrior Met Coal (HCC)?
Press Release: Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update
Dow Jones  ·  04-02
Press Release: Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update
Press Release: Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
Dow Jones  ·  04-01
Press Release: Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
Coal Stocks Have (Mostly) Benefited from the Iran War. This One Is Falling Like a Rock. -- Barrons.com
Dow Jones  ·  03-31
Coal Stocks Have (Mostly) Benefited from the Iran War. This One Is Falling Like a Rock. -- Barrons.com
Press Release: Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth
Dow Jones  ·  03-30
Press Release: Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth
Can-Fite’s Partner Vetbiolix Completes Enrollment in Phase 2 Osteoarthritis Study in Dogs Treated with Piclidenoson; Data Expected in Q3 2026
GlobeNewswire  ·  03-30
Can-Fite’s Partner Vetbiolix Completes Enrollment in Phase 2 Osteoarthritis Study in Dogs Treated with Piclidenoson; Data Expected in Q3 2026
Warrior Met Coal Is Maintained at Buy by UBS
Dow Jones  ·  03-27
Warrior Met Coal Is Maintained at Buy by UBS
Warrior Met Coal price target raised to $105 from $101 at UBS
TIPRANKS  ·  03-27
Warrior Met Coal price target raised to $105 from $101 at UBS
Press Release: Akeso Reports Full-Year 2025 Financial Results
Dow Jones  ·  03-27
Press Release: Akeso Reports Full-Year 2025 Financial Results

Introduction

Company Name.
Warrior Met Coal LLC
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Warrior Met Coal, Inc. produces and exports non-thermal metallurgical coal for the steel industry. It operates two underground mines located in Alabama. The company sells its metallurgical coal to a customer base of blast furnace steel producers located primarily in Europe, South America, and Asia. It also sells natural gas, which is extracted as a byproduct from coal production. Warrior Met Coal, Inc. was incorporated in 2015 and is headquartered in Brookwood, Alabama.
Issue price:
--